The implication of several DDR elements in the resistance of NB to therapy has been proposed, with TP53 [32–34], antiapoptotic Bcl-2 family members such as Bcl-2 [35] or Bcl-XL [36], and checkpoint regulators [37], being the most characterized. Here, BCL2 is linked to neuroblastoma.